Thomas W. LeBlanc, MD, MA and Amy P. Abernethy, MD, PhD
One strategy to promote adherence is the use of “care pathways,” effectively roadmaps that seek to standardize cancer treatment on the basis of some agreed-upon set of guidelines within a particular center or group of patients.
Both public health agencies and vaccine companies have a stake in promulgating good information about vaccines: where the government sees gaps in immunization coverage, vaccine manufacturers see gaps in market coverage. Why shouldn't they work together to close them?